239 related articles for article (PubMed ID: 17938571)
1. Putative association of Fas and FasL gene polymorphisms with clinical outcomes of hepatitis B virus infection.
Jung YJ; Kim YJ; Kim LH; Lee SO; Park BL; Shin HD; Lee HS
Intervirology; 2007; 50(5):369-76. PubMed ID: 17938571
[TBL] [Abstract][Full Text] [Related]
2. Association of TNF-alpha promoter polymorphisms with the clearance of hepatitis B virus infection.
Kim YJ; Lee HS; Yoon JH; Kim CY; Park MH; Kim LH; Park BL; Shin HD
Hum Mol Genet; 2003 Oct; 12(19):2541-6. PubMed ID: 12915457
[TBL] [Abstract][Full Text] [Related]
3. SPP1 polymorphisms associated with HBV clearance and HCC occurrence.
Shin HD; Park BL; Cheong HS; Yoon JH; Kim YJ; Lee HS
Int J Epidemiol; 2007 Oct; 36(5):1001-8. PubMed ID: 17496055
[TBL] [Abstract][Full Text] [Related]
4. Putative association of transforming growth factor-alpha polymorphisms with clearance of hepatitis B virus and occurrence of hepatocellular carcinoma in patients with chronic hepatitis B virus infection.
Kim YJ; Kim HY; Kim JS; Lee JH; Yoon JH; Kim CY; Park BL; Cheong HS; Bae JS; Kim S; Shin HD; Lee HS
J Viral Hepat; 2010 Jul; 17(7):518-26. PubMed ID: 19780938
[TBL] [Abstract][Full Text] [Related]
5. [Association between CCR5 promoter polymorphisms and hepatitis B virus infection].
Chang HY; Ahn SH; Kim DY; Shin JS; Kim YS; Hong SP; Chung HJ; Kim SO; Yoo WD; Han KH
Korean J Hepatol; 2005 Jun; 11(2):116-24. PubMed ID: 15980670
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms of death pathway genes FAS and FASL and risk of premalignant gastric lesions.
Hsu PI; Lu PJ; Wang EM; Ger LP; Lo GH; Tsay FW; Chen TA; Yang HB; Chen HC; Lin WS; Lai KH
Anticancer Res; 2008; 28(1A):97-103. PubMed ID: 18383830
[TBL] [Abstract][Full Text] [Related]
7. Association of HLA-DRB1*13 and TNF-alpha gene polymorphisms with clearance of chronic hepatitis B infection and risk of hepatocellular carcinoma in Thai population.
Kummee P; Tangkijvanich P; Poovorawan Y; Hirankarn N
J Viral Hepat; 2007 Dec; 14(12):841-8. PubMed ID: 18070287
[TBL] [Abstract][Full Text] [Related]
8. Fas / FasL system, IL-1beta expression and apoptosis in chronic HBV and HCV liver disease.
Bortolami M; Kotsafti A; Cardin R; Farinati F
J Viral Hepat; 2008 Jul; 15(7):515-22. PubMed ID: 18331250
[TBL] [Abstract][Full Text] [Related]
9. Association between chronic hepatitis B virus infection and interleukin-10, tumor necrosis factor-alpha gene promoter polymorphisms.
Cheong JY; Cho SW; Hwang IL; Yoon SK; Lee JH; Park CS; Lee JE; Hahm KB; Kim JH
J Gastroenterol Hepatol; 2006 Jul; 21(7):1163-9. PubMed ID: 16824070
[TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphisms of IL-1A, IL-1B, IL-1RN, NFKB1, FAS, and FASL, and risk of silicosis in a Chinese occupational population.
Wu F; Xia Z; Qu Y; Tang Y; Cao D; Sun P; Christiani DC
Am J Ind Med; 2008 Nov; 51(11):843-51. PubMed ID: 18666137
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms in the FAS and FASL genes and survival of early stage non-small cell lung cancer.
Park JY; Lee WK; Jung DK; Choi JE; Park TI; Lee EB; Cho S; Park JY; Cha SI; Kim CH; Kam S; Jung TH; Jheon S
Clin Cancer Res; 2009 Mar; 15(5):1794-800. PubMed ID: 19240174
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms in promoter region of FAS and FASL gene and risk of cardia gastric adenocarcinoma.
Zhou RM; Wang N; Chen ZF; Duan YN; Sun DL; Li Y
J Gastroenterol Hepatol; 2010 Mar; 25(3):555-61. PubMed ID: 20074157
[TBL] [Abstract][Full Text] [Related]
13. The -670A > G polymorphism in the promoter region of the FAS gene is associated with necrosis in periportal areas in patients with chronic hepatitis C.
Aguilar-Reina J; Ruiz-Ferrer M; Pizarro MA; Antiñolo G
J Viral Hepat; 2005 Nov; 12(6):568-73. PubMed ID: 16255757
[TBL] [Abstract][Full Text] [Related]
14. Association of concurrent hepatitis B surface antigen and antibody to hepatitis B surface antigen with hepatocellular carcinoma in chronic hepatitis B virus infection.
Jang JS; Kim HS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Kim DJ; Lee MS; Park CK; Jeong BH; Kim YS; Jang MK
J Med Virol; 2009 Sep; 81(9):1531-8. PubMed ID: 19623669
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of death pathway genes FAS and FASL polymorphisms in chronic HBV infection.
Zamani AG; Barlas IO; Durakbasi-Dursun G; Ural O; Erdal E; Yildirim MS
Int J Immunogenet; 2013 Dec; 40(6):482-7. PubMed ID: 23560484
[TBL] [Abstract][Full Text] [Related]
16. Study of Fas (CD95) and FasL (CD178) polymorphisms in liver transplant recipients.
Marín LA; Muro M; Moya-Quiles MR; Miras M; Minguela A; Bermejo J; Sanchez-Bueno F; Parrilla P; Alvarez-López MR
Tissue Antigens; 2006 Feb; 67(2):117-26. PubMed ID: 16441482
[TBL] [Abstract][Full Text] [Related]
17. Functional polymorphisms in FAS and FASL contribute to increased apoptosis of tumor infiltration lymphocytes and risk of breast cancer.
Zhang B; Sun T; Xue L; Han X; Zhang B; Lu N; Shi Y; Tan W; Zhou Y; Zhao D; Zhang X; Guo Y; Lin D
Carcinogenesis; 2007 May; 28(5):1067-73. PubMed ID: 17183065
[TBL] [Abstract][Full Text] [Related]
18. Virological and clinical implication of core promoter C1752/V1753 and T1764/G1766 mutations in hepatitis B virus genotype D infection in Mongolia.
Elkady A; Tanaka Y; Kurbanov F; Oynsuren T; Mizokami M
J Gastroenterol Hepatol; 2008 Mar; 23(3):474-81. PubMed ID: 18318825
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-18 promoter polymorphisms and the disease progression of Hepatitis B virus-related liver disease.
Migita K; Sawakami-Kobayashi K; Maeda Y; Nakao K; Kondoh S; Sugiura M; Kawasumi R; Segawa O; Tajima H; Machida M; Nakamura M; Yano K; Abiru S; Kawasaki E; Yatsuhashi H; Eguchi K; Ishibashi H
Transl Res; 2009 Feb; 153(2):91-6. PubMed ID: 19138654
[TBL] [Abstract][Full Text] [Related]
20. Genetic polymorphism of interferon-gamma, interferon-gamma receptor, and interferon regulatory factor-1 genes in patients with hepatitis B virus infection.
Cheong JY; Cho SW; Chung SG; Lee JA; Yeo M; Wang HJ; Lee JE; Hahm KB; Kim JH
Biochem Genet; 2006 Jun; 44(5-6):246-55. PubMed ID: 16944293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
